Latest Strategy News

Alexium International Group has acquired Microtek Laboratories’ microencapsulation business, marking a strategic pivot to manufacturing-led growth and raising $4.6 million to fund expansion. Despite a slight sales dip, the company is poised for a stronger 2026 with new product lines and military trials underway.

The Star Entertainment Group reported a 6% revenue increase to $301 million and a return to EBITDA profit in Q2 FY26, driven by stable Sydney trading, seasonal Gold Coast strength, and a key Brisbane operator fee. Strategic investments and refinancing efforts mark a pivotal phase for the company.

BOA Resources has secured a significant foothold in Western Australia’s Murchison Copper Belt with a 49% stake in the Neds Creek copper project, setting the stage for targeted drilling and exploration backed by a $3.75 million capital raise.

Cluey Ltd reports a 13% improvement in operating cash outflow and a 0.7% rise in gross profit margin, while preparing to launch its AI-driven Cluey+ platform in February 2026. The company also completed a $4.5 million capital raise and signed an agreement to acquire the Art of Smart group.

Locksley Resources has made significant strides at its Mojave Project, advancing drilling, securing major US institutional funding, and forging key partnerships to establish a domestic supply chain for critical antimony and rare earth elements.

Beetaloo Energy Australia Limited reported a solid cash position of $17.96 million at the end of December 2025, supported by $6.8 million in unused financing facilities. The company’s liquidity covers approximately 2.6 quarters of current cash outflows, positioning it well as it awaits the activation of a new $30 million infrastructure facility.

QPM Energy has secured key contracts and financing milestones for its 112MW Isaac Power Station, while managing stable gas supply amid weak electricity prices.

Viking Mines has entered a binding agreement to acquire six high-grade tungsten projects in Nevada, backed by a strategic investment from American Tungsten Corp and a $4.29 million capital raise. The acquisition marks a significant expansion into the critical US tungsten market amid rising global demand.

Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.

Celsius Resources has delivered a robust Definitive Feasibility Study for its Maalinao-Caigutan-Biyog Copper-Gold Project, confirming a 35-year mine life and strong economic returns. The company is actively progressing funding arrangements amid growing investor interest.

Nimy Resources has announced a maiden JORC Inferred Resource for high-grade gallium and rare earth elements at its Mons Project in Western Australia, marking a significant step towards becoming a key supplier in critical minerals.

Vita Resources NL, formerly Bastion Minerals, has advanced its Canadian and Australian projects with new exploration agreements and acquisitions, supported by a recent capital raise. The company is gearing up for significant exploration activities in 2026 under its refreshed corporate identity.